ABSTRACT
Background: Coronaviruses are a large family of viruses that can cause respiratory infections. A factor that has recently caused a great deal of anxiety is anxiety associated with the coronavirus. The purpose of this study was to evaluate the level of anxiety among medical personnel exposed to the new coronavirus pandemic. Methods: This descriptive, cross-sectional research was conducted on 210 medical personnel working in hospitals and health centers in Tasikmalaya, Indonesia. Medical personnel, who were exposed to or not exposed to this disease, were included in the study through census sampling in 2021. The data collection tools used include a demographic information questionnaire and the Corona disease anxiety scale (CDAS). Data analysis was performed using ANCOVA in Excel software. Results: The mean score of anxiety of the medical personnel during the new coronavirus pandemic in Tasikmalaya was 30.02%. Furthermore, in the medical personnel, the mean score of mental symptoms (47.22%) was higher than physical symptoms (13.15%). The anxiety, and psychological, and physical symptoms scores for women was higher than for men personnel, and there was a significant difference between them (P ˂ 0.05). The demographic variables of gender (P = 0.001), work experience (P = 0.023), and number of family members (P = 0.004) had a statistically significant relationship with anxiety (P < 0.05). Conclusion: According to the results of the study, the level of anxiety among female personnel was higher than male personnel. As a result, holding training classes and stress management courses among all personnel, especially female personnel, should be considered. © 2023, Vesnu Publications. All rights reserved.
ABSTRACT
Coronavirus disease (COVID-19) appeared as outbreak in 2019 in Wuhan, China. It has been classified as pandemic disease and more severe than predicted;with infections already recorded in a variety of countries. This study aims to confirm the COVID-19 infection through the following tests: hematological, C-reactive protein (CRP). Samples were collected from the infected patients and sent to the National Flu Center (Central Public Health Laboratory) for COVID-19 (positive or negative) diagnosis by the RT-PCR technique. In this study, sixty five of COVID-19 patients and twenty five of healthy control samples male and female were collected in Iraq. There are significant differences in the parameters of the hematological markers for patients in comparing with the control group and no significant differences were observed in Hb when RBC and GRAN percent rise in patients relative to the control group with P=0.0395 and P=0.0354 respectively comparing with the control group. White blood cells (WBC), Lymphocyte (LYM%), Platelets (PIT), monocyte (Mid%), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean platelet volume (MPV), plateletcrit (PCT) was drop dramatically in patients compared to control group. Fifty-one of patients for whom the test was given exhibited a positive (CRP) result. Likewise, the results showed that few patients were negative to CRP test. The Hematological parameters levels (HCT, MCV, MCH, Pelt, WBC, LYM, Mid, MPV, PCT) decreased, but Hb, RBC, GRAN% increased. C-reactive protein test showed a positive result in 85% of patients which can be considered an indicator for predicting severity infection with COVID-19. © 2022. All Rights Reserved.
ABSTRACT
Coronavirus disease (COVID-19) appeared as outbreak in 2019 in Wuhan, China. It has been classified as pandemic disease and more severe than predicted;with infections already recorded in a variety of countries. This study aims to confirm the COVID-19 infection through the following tests: hematological, C-reactive protein (CRP). Samples were collected from the infected patients and sent to the National Flu Center (Central Public Health Laboratory) for COVID-19 (positive or negative) diagnosis by the RT-PCR technique. In this study, sixty five of COVID-19 patients and twenty five of healthy control samples male and female were collected in Iraq. There are significant differences in the parameters of the hematological markers for patients in comparing with the control group and no significant differences were observed in Hb when RBC and GRAN percent rise in patients relative to the control group with P=0.0395 and P = 0.0354 respectively comparing with the control group. White blood cells (WBC), Lymphocyte (LYM%), Platelets (PIT), monocyte (Mid%), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean platelet volume (MPV), plateletcrit (PCT) was drop dramatically in patients compared to control group. Fifty-one of patients for whom the test was given exhibited a positive (CRP) result. Likewise, the results showed that few patients were negative to CRP test. The Hematological parameters levels (HCT, MCV, MCH, Pelt, WBC, LYM, Mid, MPV, PCT) decreased, but Hb, RBC, GRAN% increased. C-reactive protein test showed a positive result in 85% of patients which can be considered an indicator for predicting severity infection with COVID-19.
ABSTRACT
Introduction: The outbreak of novel coronavirus COVID-19 infections that started in China late 2019 has spread rapidly and cases have been recorded worldwide. So, in this study, we sought clarification of the clinical characteristics and importance of changing the lymphocyte group, antibodies, CD markers, and interleukin-6 in the serum of COVID-19 patients, which may help to clarify the pathogen and develop new biomarkers. Material and Methods: Venous blood samples had been accumulated from patients before taking any medications. Sera had been separated and saved at (-20°C) until analysis. Serum anti-SARS-CoV-2 immunoglobulins (IgG, IgA, and IgM) were determined in plasma samples using enzyme-linked immunosorbent assays (ELISA) and Serum IL-6 was assessed. Results: Median IgM (p=0.001), IgG (p<0.0001), and IgA (p<0.001), were decreased in patients comparing with control the control group. There is a significant decrease in CD3+ and CD4+ cells compared to healthy individuals in patients infected with COVID-19 (p<0.0001). CD19+ cell count decreased in COVID-19 patients compared to that of the control group (p<0.0001). After calculating CD4+/CD8+ cell ratio decreased in COVID-19 patients (p<0.0001). However, CD56+ cells were found to be increased (p<0.0001). Conclusions: IgM, IgG, IgA levels and CD19+, CD4+ cells, CD4+/CD8+ cell ratio were found to be decreased whereas CD8+, CD3+, CD4+ cells were detected to be increased in COVID-19 patients compared to those of healthy controls. © 2020 Turkish Journal of Immunology.